RSV awareness, risk perception, causes, and terms: Comment

RSV awareness, risk perception, causes, and terms: Comment

ABSTRACTThis correspondence discusses on res awpiratory syncytial virus areness, risk perception and causes. Important limitations and possible furture direction for researching are mentioned.

Bibliographic Details
Main Authors:	Somsri Wiwanitkit, Viroj Wiwanitkit
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-12-01
Series:	Human Vaccines & Immunotherapeutics
Subjects:	RSV vaccine policy
Online Access:	https://www.tandfonline.com/doi/10.1080/21645515.2023.2277086

Similar Items

RSV awareness, risk perception, causes, and terms: Perspectives of pregnant and lactating women in Kenya to inform demand generation efforts for maternal RSV vaccines
by: Rupali J. Limaye, et al.
Published: (2023-08-01)

RSV disease in infants and young children: Can we see a brighter future?
by: Eugenio Baraldi, et al.
Published: (2022-11-01)

RSV Disease Threat and Innovative Prevention Methods in Health Protection: A Review
by: Paulina Dąbrowska, et al.
Published: (2024-02-01)

RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein
by: Harrison C. Bergeron, et al.
Published: (2022-10-01)

A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV Infection
by: Kathrin Endt, et al.
Published: (2022-06-01)

Correlative outcomes of maternal immunization against RSV in cotton rats
by: Jorge C. G. Blanco, et al.
Published: (2022-12-01)

Adjuvant Selection for Influenza and RSV Prefusion Subunit Vaccines
by: Ariel Isaacs, et al.
Published: (2021-01-01)

New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV
by: Nicolás M. S. Gálvez, et al.
Published: (2017-08-01)

Dominance of the ON1 Genotype of RSV-A and BA9 Genotype of RSV-B in Respiratory Cases from Jeddah, Saudi Arabia
by: Hessa A. Al-Sharif, et al.
Published: (2020-11-01)

RSV: perspectives to strengthen the need for protection in all infants
by: Jose Antonio Navarro Alonso, et al.
Published: (2021-10-01)

Maternal RSV vaccine development. Where to from here?
by: Ahinsa Gunatilaka, et al.
Published: (2021-11-01)

Utility of the Neonatal Calf Model for Testing Vaccines and Intervention Strategies for Use against Human RSV Infection
by: Mariana Guerra-Maupome, et al.
Published: (2019-01-01)

Reducing respiratory syncytial virus (RSV) hospitalization in a lower-income country by vaccinating mothers-to-be and their households
by: Samuel PC Brand, et al.
Published: (2020-03-01)

RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models
by: Freek Cox, et al.
Published: (2023-03-01)

An Optimized FI-RSV Vaccine Effectively Protects Cotton Rats and BALB/c Mice without Causing Enhanced Respiratory Disease
by: Min Lin, et al.
Published: (2022-09-01)

Immunopathogenesis associated with formaldehyde-inactivated RSV vaccine in preclinical and clinical studies
by: Abenaya Muralidharan, et al.
Published: (2017-04-01)

Level of maternal respiratory syncytial virus (RSV) F antibodies in hospitalized children and correlates of protection
by: Sara A. Taleb, et al.
Published: (2021-08-01)

Ebola vaccine 2014: remained problems to be answered
by: Somsri Wiwanitkit, et al.
Published: (2015-02-01)

Improved epitope resolution of the prefusion trimer-specific antibody AM14 bound to the RSV F glycoprotein
by: Wayne Harshbarger, et al.
Published: (2021-01-01)

Epidemiology and molecular characteristics of respiratory syncytial virus (RSV) among italian community-dwelling adults, 2021/22 season
by: Donatella Panatto, et al.
Published: (2023-03-01)

Respiratory Syncytial Virus Prevention through Monoclonal Antibodies: A Cross-Sectional Study on Knowledge, Attitudes, and Practices of Italian Pediatricians
by: Matteo Riccò, et al.
Published: (2023-02-01)

Clinical research on RSV prevention in children and pregnant women: progress and perspectives
by: Xuejia Gong, et al.
Published: (2024-01-01)

Immunogenicity and protective efficacy of an RSV G S177Q central conserved domain nanoparticle vaccine
by: Harrison C. Bergeron, et al.
Published: (2023-06-01)

Ethical concerns regarding heterologous COVID-19 vaccine administration
by: Somsri Wiwanitkit, et al.
Published: (2024-12-01)

Humoral response against spike protein and fifth and sixth COVID-19 mRNA vaccine in the uninfected and infected subjects: What should be for the seventh dose?
by: Somsri Wiwanitkit, et al.
Published: (2023-12-01)

Hemophagocytic lymphohistiocytosis (HLH) after COVID-19 vaccination
by: Somsri Wiwanitkit, et al.
Published: (2023-12-01)

Targeting Host Cell Surface Nucleolin for RSV Therapy: Challenges and Opportunities
by: Peter Mastrangelo, et al.
Published: (2017-09-01)

Innate Immune Components That Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections
by: Catalina A. Andrade, et al.
Published: (2020-06-01)

All Eyes on the Prefusion-Stabilized F Construct, but Are We Missing the Potential of Alternative Targets for Respiratory Syncytial Virus Vaccine Design?
by: Sofie Schaerlaekens, et al.
Published: (2024-01-01)

A multifaceted approach to RSV vaccination
by: Jorge C. G. Blanco, et al.
Published: (2018-07-01)

Local variations in the timing of RSV epidemics
by: Douglas B. Noveroske, et al.
Published: (2016-11-01)

Lessons learned from COVID-19 vaccine acceptance among pregnant and lactating women from two districts in Kenya to inform demand generation efforts for future maternal RSV vaccines
by: Rupali J. Limaye, et al.
Published: (2024-03-01)

Non-Coding RNAs and Their Role in Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV) Infections
by: Wenzhe Wu, et al.
Published: (2020-03-01)

Immunity to RSV in Early Life
by: Laura eLambert, et al.
Published: (2014-09-01)

IFN-γ Attenuates Eosinophilic Inflammation but Is Not Essential for Protection against RSV-Enhanced Asthmatic Comorbidity in Adult Mice
by: Abenaya Muralidharan, et al.
Published: (2022-01-01)

Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development
by: Seyhan Boyoglu-Barnum, et al.
Published: (2019-07-01)

The respiratory syncytial virus (RSV) prefusion F‐protein functional antibody repertoire in adult healthy donors
by: Emanuele Andreano, et al.
Published: (2021-06-01)

RSV Vaccine Based on Rhabdoviral Vector Protects after Single Immunization
by: Sarah Wilmschen, et al.
Published: (2019-07-01)

RSV infection and recurrence of respiratory tract obstruction in children
by: Karolina Kapusta, et al.
Published: (2016-06-01)

Bovine IgG Prevents Experimental Infection With RSV and Facilitates Human T Cell Responses to RSV
by: Maaike Nederend, et al.
Published: (2020-08-01)